ANDA 202978, held by Dr. Reddy's Laboratories. Fexofenadine Hydrochloride.
As of Nov 21, 2026, ANDA 202978 (Children's Fexofenadine Hydrochloride Allergy, Children's Fexofenadine Hydrochloride Hives), held by Dr. Reddy's Laboratories, was first approved by FDA on Jan 18, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 18, 2013 | Original application | Approved |
| Children's Fexofenadine Hydrochloride Allergy30MG · tablet, orally disintegrating;oral | Fexofenadine Hydrochloride | Discontinued |
| Children's Fexofenadine Hydrochloride Hives30MG · tablet, orally disintegrating;oral | Fexofenadine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters